Polycystins and cellular Ca(2+) signaling

por Mekahli, D., Parys, Jan B., Bultynck, G., Missiaen, L., De Smedt, H.
Publicado 2012

Bax Inhibitor-1 is a novel IP(3) receptor-interacting and -sensitizing protein

por Kiviluoto, S, Schneider, L, Luyten, T, Vervliet, T, Missiaen, L, De Smedt, H, Parys, J B, Methner, A, Bultynck, G
Publicado 2012

Neuroprotective properties of anti-apoptotic BCL-2 proteins in 5xFAD mouse model of Alzheimer’s disease

por Chernyuk, D., Callens, M., Polozova, M., Gordeev, A., Chigriai, M., Rakovskaya, A., Ilina, A., Pchitskaya, E., Van den Haute, C., Vervliet, T., Bultynck, G., Bezprozvanny, I.
Publicado 2023

Selective regulation of IP(3)-receptor-mediated Ca(2+) signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl

por Monaco, G, Decrock, E, Akl, H, Ponsaerts, R, Vervliet, T, Luyten, T, De Maeyer, M, Missiaen, L, Distelhorst, C W, De Smedt, H, Parys, J B, Leybaert, L, Bultynck, G
Publicado 2012

IP(3)R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP(3)R-derived peptide targeting the BH4 domain of Bcl-2

por Akl, H, Monaco, G, La Rovere, R, Welkenhuyzen, K, Kiviluoto, S, Vervliet, T, Molgó, J, Distelhorst, C W, Missiaen, L, Mikoshiba, K, Parys, J B, De Smedt, H, Bultynck, G
Publicado 2013